Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use

Detalles Bibliográficos
Autores principales: Nayak, AS, Nathan, RA, Meltzer, EO, Weinstein, SF, Nolte, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242176/
http://dx.doi.org/10.1186/1710-1492-7-S2-A15
_version_ 1782219595201904640
author Nayak, AS
Nathan, RA
Meltzer, EO
Weinstein, SF
Nolte, H
author_facet Nayak, AS
Nathan, RA
Meltzer, EO
Weinstein, SF
Nolte, H
author_sort Nayak, AS
collection PubMed
description
format Online
Article
Text
id pubmed-3242176
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32421762011-12-19 Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use Nayak, AS Nathan, RA Meltzer, EO Weinstein, SF Nolte, H Allergy Asthma Clin Immunol Meeting Abstract BioMed Central 2011-11-14 /pmc/articles/PMC3242176/ http://dx.doi.org/10.1186/1710-1492-7-S2-A15 Text en Copyright ©2011 Nayak et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Nayak, AS
Nathan, RA
Meltzer, EO
Weinstein, SF
Nolte, H
Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title_full Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title_fullStr Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title_full_unstemmed Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title_short Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
title_sort mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242176/
http://dx.doi.org/10.1186/1710-1492-7-S2-A15
work_keys_str_mv AT nayakas mometasonefuroateformoterolcombinationtherapyincreasesfrequencyofdaysnightsfreeofshortactingb2agonistuse
AT nathanra mometasonefuroateformoterolcombinationtherapyincreasesfrequencyofdaysnightsfreeofshortactingb2agonistuse
AT meltzereo mometasonefuroateformoterolcombinationtherapyincreasesfrequencyofdaysnightsfreeofshortactingb2agonistuse
AT weinsteinsf mometasonefuroateformoterolcombinationtherapyincreasesfrequencyofdaysnightsfreeofshortactingb2agonistuse
AT nolteh mometasonefuroateformoterolcombinationtherapyincreasesfrequencyofdaysnightsfreeofshortactingb2agonistuse

Ejemplares similares